Trial intelligence / Profile preview

Dexmedetomidine vs Midazolam for Sedation in Pediatric Inguinal Hernia Repair

NCT05574179Phase 1Unknown

Sponsor
Sheikh Zayed Medical College
Start
Jan 2023
Primary completion
Jul 2023
Modality
Small Molecules
01

Overview

Phase 1, randomised trial of dexmedetomidine in inguinal hernia (2 arms), sponsored by Sheikh Zayed Medical College. Primary endpoint: Ramsay Sedation Score at 25 minutes. Status: unknown.

02

Drugs

dexmedetomidine
03

Conditions

inguinal hernia

Beyond the preview

Go deeper on NCT05574179.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05574179.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call